Company: IMCR
Filing Date: 2025-03-17
Form Type: 424B7
Source: 0001140361-25-008917
Chunk: 58

Company: Immunocore Holdings plc
Filing Date: 2025-03-17
Form: 424B7
Chunk 58
---
 period in the aggregate during regular trading hours of any suspension or limitation imposed on trading (by reason of movements in price exceeding limits permitted by the relevant stock exchange or otherwise) in our ADSs or in any options contracts or futures contracts relating to our ADSs or ordinary shares.

#### Conversion Rate Adjustments
As of the date of this prospectus supplement, each of the ADSs represents one ordinary share of Immunocore Holdings plc. If the number of ordinary shares represented by the ADSs is changed for any reason other than one or more of the events described below, we will make an appropriate adjustment to the conversion rate such that the number of ordinary shares represented by the ADSs upon which conversion of the notes is based remains the same.

Notwithstanding the adjustment provisions described below, if we distribute to holders of the ordinary shares any cash, rights, options, warrants, share capital or similar equity interest, evidences of indebtedness or other assets or property of ours (but excluding expiring rights (as defined below)) and a corresponding distribution is not made to holders of the ADSs, but, instead, the ADSs will represent, in addition to the ordinary shares, such cash, rights, options, warrants, share capital or similar equity interest, evidences of indebtedness or other assets or property of ours, then a conversion rate adjustment described below will not be made until and unless a corresponding distribution (if any) is made to holders of the ADSs, and such conversion rate adjustment will be based on the distribution made to the holders of the ADSs and not on the distribution made to the holders of the ordinary shares. However, in the event that we issue or distribute to all holders of the ordinary shares any expiring rights, notwithstanding the immediately preceding sentence, we will adjust the conversion rate pursuant to the provisions set forth opposite clause (2) (in the case of expiring rights described in clause (2) below entitling holders of the ordinary shares for a period of not more than 60 calendar days after the announcement date of such issuance to subscribe for or purchase ordinary shares or ADSs) or clause (3) (in the case of all other expiring rights) below and no additional adjustment will be made upon any distribution of such expiring rights to holders of ADSs.

<div align='center'>S-33</div>

TABLE OF CONTENTS

The term “expiring rights” means any rights, options or warrants to purchase ordinary shares or ADSs that expire on or prior to the maturity date of the notes.